Mucinous carcinoma of the breast (MCB) is a rare histologic form of estrogen receptor (ER)-positive/HER2-negative breast cancer (BC) characterized by tumor cells floating in lakes of mucin. We assessed the genomic landscape of 32 MCBs by whole-exome sequencing and/or RNA-sequencing. GATA3 (23.8%), KMT2C (19.0%), and MAP3K1 (14.3%) were the most frequently mutated genes in pure MCBs. In addition, two recurrent but not pathognomonic fusion genes, OAZ1-CSNK1G2 and RFC4-LPP, were detected in 3/31 (9.7%) and 2/31 (6.5%) samples, respectively. Compared with ER-positive/HER2-negative common forms of BC, MCBs displayed lower PIK3CA and TP53 mutation rates and fewer concurrent 1q gains and 16q losses. Clonal decomposition analysis of the mucinous and ductal components independently microdissected from five mixed MCBs revealed that they are clonally related and evolve following clonal selection or parallel evolution. Our findings indicate that MCB represents a genetically distinct ER-positive/HER2-negative form of BC.

The Genomic Landscape of Mucinous Breast Cancer

Marchiò, Caterina;
2019-01-01

Abstract

Mucinous carcinoma of the breast (MCB) is a rare histologic form of estrogen receptor (ER)-positive/HER2-negative breast cancer (BC) characterized by tumor cells floating in lakes of mucin. We assessed the genomic landscape of 32 MCBs by whole-exome sequencing and/or RNA-sequencing. GATA3 (23.8%), KMT2C (19.0%), and MAP3K1 (14.3%) were the most frequently mutated genes in pure MCBs. In addition, two recurrent but not pathognomonic fusion genes, OAZ1-CSNK1G2 and RFC4-LPP, were detected in 3/31 (9.7%) and 2/31 (6.5%) samples, respectively. Compared with ER-positive/HER2-negative common forms of BC, MCBs displayed lower PIK3CA and TP53 mutation rates and fewer concurrent 1q gains and 16q losses. Clonal decomposition analysis of the mucinous and ductal components independently microdissected from five mixed MCBs revealed that they are clonally related and evolve following clonal selection or parallel evolution. Our findings indicate that MCB represents a genetically distinct ER-positive/HER2-negative form of BC.
2019
117
7
737
741
Muinous carcinoma, breast, HER2
Pareja, Fresia; Lee, Ju Youn; Brown, David N; Piscuoglio, Salvatore; Gularte-Mérida, Rodrigo; Selenica, Pier; Da Cruz Paula, Arnaud; Arunachalam, Sasi; Kumar, Rahul; Geyer, Felipe C; Silveira, Catarina; da Silva, Edaise M; Li, Anqi; Marchiò, Caterina; Ng, Charlotte K Y; Mariani, Odette; Fuhrmann, Laetitia; Wen, Hannah Y; Norton, Larry; Vincent-Salomon, Anne; Brogi, Edi; Reis-Filho, Jorge S; Weigelt, Britta
File in questo prodotto:
File Dimensione Formato  
djy216.pdf

Accesso riservato

Descrizione: J Natl Cancer Inst. 2019 Jan 11
Tipo di file: PDF EDITORIALE
Dimensione 1.13 MB
Formato Adobe PDF
1.13 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1717848
Citazioni
  • ???jsp.display-item.citation.pmc??? 39
  • Scopus 57
  • ???jsp.display-item.citation.isi??? 51
social impact